You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 1101 to 1125 of about 5901
Next 25
04/29/2019
The efficacy of a coordinated pharmacological blockade in glioblastoma stem cells with nine repurposed drugs using the CUSP9 strategy.
04/27/2019
Leptomeningeal metastases in glioma
Correlation of Tumor Treating Fields dosimetry to survival outcomes in newly diagnosed glioblastoma: A large-scale numerical simulation-based analysis of data from the Phase 3 EF-14 randomized trial.
National Walk To End Brain Tumors
04/20/2019
Cancer and the dopamine D2 receptor: a pharmacological perspective.
04/18/2019
Liquid Biopsy for Detection of Histone H3 Mutations in Pediatric Diffuse Midline Gliomas
04/15/2019
Use of metformin and outcome of patients with newly diagnosed glioblastoma - pooled analysis.
Successful treatment of brain radiation necrosis resulting from triple-negative breast cancer with Endostar and short-term hyperbaric oxygen therapy: a case report
04/11/2019
`I Love What I Do` - Internationally Renowned Brain Surgeon Dr. Linda Liau
04/09/2019
Case Report in the Journal of Neurosurgery Highlights Potential of ONC201 in H3 K27M-mutant DIPG
Optune Open Houses
04/03/2019
Phase 2 study of Val-083 with radiation therapy for newly diagnosed
New Glioblastoma Vaccine Shows Promising Results in Phase 1b Clinical Trial
High frequency of H3K27M immunopositivity in adult thalamic glioblastoma.
03/31/2019
New glioblastoma vaccine shows promising results in phase Ib clinical trial
Could £400-per-year drug cocktail be the key to beating one of the most-deadly cancers?
03/28/2019
New Strategies Take On the Worst Cancer—Glioblastoma
03/20/2019
Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma.
03/15/2019
First-Of-Its-Kind Treatment Beats Back Notorious Brain Tumor
03/14/2019
03/13/2019
Newly Diagnosed Glioblastoma: A Review on Clinical Management
03/12/2019
A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma
Northwell neurosurgeons remove “glowing” brain tumor using breakthrough technology in Long Island first